2730-664x

Communications Medicine

Springer Science and Business Media LLC

View prefix report (10.1038)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 823 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact823 DOIs
2

Deposit reference lists for 158 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact158 DOIs
3

Attach ORCID iDs across 70 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact70 DOIs

DOIs for this ISSN

Showing the top 5 of 1751 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Advances in oncolytic virotherapy (10.1038/s43856-022-00098-4)
Abstract References ORCID
110.78 29
2 Global disparities in access to cancer care (10.1038/s43856-022-00097-5)
Abstract ORCID
89.62 61
3 Patient involvement in clinical trials (10.1038/s43856-022-00156-x)
Abstract ORCID
82.66 44
4 Next steps in the early detection of ovarian cancer (10.1038/s43856-021-00037-9)
Abstract ORCID
74.57 30
5 Clinical trials and pregnancy (10.1038/s43856-022-00198-1)
Abstract ORCID
66.11 20
6 Mitigating bias in machine learning for medicine (10.1038/s43856-021-00028-w)
Abstract
59.23 233
7 Author Correction: Challenges in implementing cultural adapt… (10.1038/s43856-024-00479-x)
Abstract References ORCID
52.42 4
8 Multi-model assurance analysis showing large language models… (10.1038/s43856-025-01021-3)
Abstract
52.07 120
9 Challenges in implementing cultural adaptations of digital h… (10.1038/s43856-023-00426-2)
ORCID
46.58 72
10 Harnessing artificial intelligence to improve clinical trial… (10.1038/s43856-023-00425-3)
Abstract
46.13 69
11 Resisting disinfectants (10.1038/s43856-021-00070-8)
Abstract
45.65 66
12 Individualized ASO therapy for rare diseases (10.1038/s43856-023-00255-3)
Abstract References ORCID
45.15 3
13 Antimicrobial drug pricing (10.1038/s43856-024-00594-9)
Abstract ORCID
45.15 7
14 Insights from teaching artificial intelligence to medical st… (10.1038/s43856-022-00125-4)
Abstract
43.51 54
15 The influence of socioeconomic status on individual attitude… (10.1038/s43856-024-00586-9)
Abstract
42.47 49
16 The contribution of human conflict to the development of ant… (10.1038/s43856-023-00386-7)
Abstract
41.57 45
17 Disparities in steatosis prevalence in the United States by… (10.1038/s43856-024-00649-x)
Abstract
41.57 45
18 The teachings of Long COVID (10.1038/s43856-021-00016-0)
Abstract
40.58 41
19 Epidemiology and future trend predictions of ischemic stroke… (10.1038/s43856-025-00939-y)
Abstract
40.58 41
20 How will artificial intelligence change medical training? (10.1038/s43856-021-00003-5)
Abstract
40.32 40
21 Rapamycin treatment for Alzheimer’s disease and related deme… (10.1038/s43856-025-00904-9)
Abstract
40.32 40
22 Development of a large-scale medical visual question-answeri… (10.1038/s43856-024-00709-2)
Abstract
40.05 39
23 Author Correction: Performance assessment and economic analy… (10.1038/s43856-023-00249-1)
Abstract References
38.91 5
24 Biomarkers and point of care screening approaches for the ma… (10.1038/s43856-024-00642-4)
Abstract
38.60 34
25 Regulating the AI-enabled ecosystem for human therapeutics (10.1038/s43856-025-00910-x)
Abstract
37.96 32
26 A multistakeholder approach to innovations in NAFLD care (10.1038/s43856-022-00228-y)
Abstract
37.63 31
27 Advancing the frontiers of geographic accessibility to healt… (10.1038/s43856-023-00391-w)
Abstract
37.28 30
28 Development and preliminary validation of infrared spectrosc… (10.1038/s43856-022-00104-9)
ORCID
36.93 29
29 Machine learning for early dynamic prediction of functional… (10.1038/s43856-024-00666-w)
Abstract
36.93 29
30 Integrating social nutrition principles into the treatment o… (10.1038/s43856-023-00398-3)
Abstract
36.56 28
31 Recent advances in CRISPR-based single-nucleotide fidelity d… (10.1038/s43856-025-00933-4)
Abstract
36.56 28
32 Patient engagement and involvement in rare disease research (10.1038/s43856-023-00251-7)
Abstract References ORCID
35.78 2
33 FORCE platform overcomes barriers of oligonucleotide deliver… (10.1038/s43856-025-00733-w)
Abstract
35.78 26
34 Revealing excitation-inhibition imbalance in Alzheimer’s dis… (10.1038/s43856-025-00736-7)
Abstract
35.78 26
35 Challenges and standardisation strategies for sensor-based d… (10.1038/s43856-025-01013-3)
Abstract
35.78 26
36 Introducing Communications Medicine (10.1038/s43856-021-00009-z)
Abstract ORCID
34.95 4
37 A mission to understand space anaemia (10.1038/s43856-022-00078-8)
Abstract ORCID
34.95 4
38 Exposure to multiple ambient air pollutants changes white ma… (10.1038/s43856-024-00576-x)
Abstract
34.95 24
39 The current and future landscape of RNA-based therapies and… (10.1038/s43856-025-01166-1)
Abstract ORCID
34.95 4
40 Predicting pediatric patient rehabilitation outcomes after s… (10.1038/s43856-024-00726-1)
Abstract
34.51 23
41 Deep proteome profiling of metabolic dysfunction-associated… (10.1038/s43856-025-00780-3)
Abstract
34.51 23
42 Recent clinical trials inform the future for malaria vaccine… (10.1038/s43856-021-00030-2)
Abstract
34.04 22
43 A nationwide study of risk factors for long COVID and its ec… (10.1038/s43856-025-00759-0)
Abstract
34.04 22
44 Interpretable machine learning leverages proteomics to impro… (10.1038/s43856-025-00872-0)
Abstract
34.04 22
45 Global trends of antimicrobial resistance and virulence of K… (10.1038/s43856-025-01112-1)
Abstract
34.04 22
46 Demographic factors impact the rate of hearing decline acros… (10.1038/s43856-024-00593-w)
Abstract
33.56 21
47 Discriminating Myalgic Encephalomyelitis/Chronic Fatigue Syn… (10.1038/s43856-024-00669-7)
Abstract
33.56 21
48 Genetically engineered pig heart transplantation in non-huma… (10.1038/s43856-025-00731-y)
Abstract
33.56 21
49 Brain age gap as a predictive biomarker that links aging, li… (10.1038/s43856-025-01100-5)
Abstract
33.56 21
50 AAV9-cBIN1 gene therapy rescues chronic heart failure due to… (10.1038/s43856-025-00787-w)
Abstract
33.06 20